Clinical Scorecard: Key Challenges in Conducting Experimental Medicine Studies
At a Glance
Category
Detail
Condition
Challenges in designing and conducting human experimental medicine studies
Key Mechanisms
Mechanisms or clinical associations described in the source article.
Target Population
Patients or participants described in the source article.
Care Setting
Care setting described in the source article.
Key Highlights
Experimental medicine studies may prioritize depth of knowledge over statistical power when evidence for power calculations is limited.
Extensive outcome measures can require invasive procedures, specialized expertise, and protocols for consistent sample handling.
Study design should account for participant willingness to undertake lengthy visits and the availability of teams to perform and interpret procedures.
The AuToDeCRA-2 example shows how manufacturing capacity, quality-control schedules, and staff availability can constrain treatment timing.
The article identifies project management, rehearsals, and representative, inclusive recruitment with patient and public involvement and engagement as ways to address study challenges.
Guideline-Based Recommendations
Diagnosis
Management
Plan outcome measures in relation to the study question, participant burden, available procedural expertise, and capacity to analyse and interpret results.
Establish sample-handling protocols to maintain consistent sample quality.
Map timing dependencies and personnel availability; the AuToDeCRA-2 team used a 12-month logistics spreadsheet and periodically rechecked availability.
Monitoring & Follow-up
Consider linking clinical or imaging outcomes with blood pharmacokinetics and tissue pharmacodynamics when relevant to the study question.
Risks
Patient & Prescribing Data
In AuToDeCRA-2, the product was manufactured from participants’ own blood cells. The protocol scheduled dosing 10 days after leukapheresis and required specified procedures at points in the participant’s study progression.
Clinical Best Practices
Define the study question and select outcome measures that the team can perform, analyse, and interpret.
Involve relevant clinical, laboratory, imaging, pharmacy, manufacturing, and quality-control personnel in planning.
Schedule key procedures and sample processing around operational constraints, and identify backup personnel.
Plan recruitment to be representative and inclusive, with robust patient and public involvement and engagement.
Machine-learning models distinguished healthy knees from those with osteoarthritis-related cartilage damage, but age and BMI performed as well as or better than the vibration-based models.
